Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVERIMEN Study: Stemsap-A for Androgenetic Alopecia in Men
jRCTs051240303Active, not recruiting
- Start
- Jun 2025
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label, single-arm trial of Stemsap-A in androgenetic alopecia (AGA). Primary endpoint: Change in scalp hair density from baseline to week 32. Started Jun 2025; status: active, not recruiting.
02
Drugs
Stemsap-A
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on jRCTs051240303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051240303.